Free Light Chains & Monoclonal Gammopathies
Impact on Diagnostic Panels
Plasma Cell Proliferative Disorders
August 2008
The testing we’re talking about are tests to indentify virtually all of these plasma cell proliferative disorders by indentifying the presence of monoclonal gammopathy. That is, diagnosing a monoclonal immunoglobulin. In addition to diagnostic uses PEL, IFE and free light chain assays may be useful for prognosis of either progression or survival and also may be used for disease monitoring.
Plasma Cell Proliferative Disorders |
Jump to section:
- Introduction
- Diagnostic Tests
- Mayo Clinic 1960-2003
- Plasma Cell Proliferative Disorders
- Serum Protein Electrophoresis & Immunofixation Electrophoresis
- Serum Protein Electrophoresis & Immunofixation Electrophoresis
- Monoclonal Serum Proteins: Newly Diagnosed Multiple Myeloma (n=1027)
- Serum Protein Electrophoresis & Immunofixation Electrophoresis
- Urine Protein Electrophoresis & Immunofixation Electrophoresis
- Intact Immunoglobulin/Free Light Chain
- FLC Reference Range
- Diagnoses for 428 Patients Selected for Urine Monoclonal Protein
- Serum PEL & IFE Results: 428 Pts with Urine Monoclonal Protein
- Laboratory Results: 428 Patients with Monoclonal Urinary Protein
- Potential Savings
- Uses of Serum Free Light Chain Assay
- Diagnostic Test Panel for Suspected Monoclonal Gammopathies
- Questions?
External
link
PDF
document
Excel
document
Word
document